Genetic Analysis launches GA-map test for infants
This article was originally published in Clinica
Executive Summary
Norwegian molecular diagnostics specialist Genetic Analysis has launched its GA-map test for analysing gut microbes in infants. It is now available worldwide for research use only. GA-map works on the principle that many disorders could be linked to an imbalance in the gut microbial profile, including inflammatory bowel disease, allergy, autism and obesity. The product can process more than 200 samples per day, the Aas-based company claims. GA-map could increase understanding of the causes of disease by highlighting differences in microbial profiles between patients and healthy controls. "Looking ahead, the technology could be used to develop intelligent treatments based on personalised medicine," said the firm's CEO, Dr Morten Isaksen. Genetic Analysis is also developing an adult version of the test.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.